Solitary bone plasmocytoma: treatment and outcome features

Cancer Radiother. 2004 Apr;8(2):70-4. doi: 10.1016/j.canrad.2003.11.003.
[Article in English, French]

Abstract

Purpose: - To describe natural history of solitary bone plasmocytomas (SBO) after treatment.

Patients and methods: - Between 1975 and 1998, we retrospectively identified 13 patients with SBO treated in the department of radiotherapy at Salah-Azaïz institute of Tunis. To be included in this study, three criteria were needed: histologic confirmation and only one bone lesion without medullary infiltration (or less than 10%). Mean age was 43 years (22-64) with sex-ratio of 3,3. Tumor sites were vertebra (6), flat bones (6) and tibia (1). Megavoltage radiotherapy was given to all patients, associated to surgery in eight cases (5 excisions and 3 laminectomies) and to chemotherapy in three.

Results: - With a mean follow-up of 63 months, two local failures were noted at 24 and 48 months. Two patients developed multifocal lesions and one patient had an extramedullary lesion. Multiple myeloma occurred in four patients (30%) after a median follow-up 3,5 years. Unfavorable outcome could not be predicted by age, gender or site of disease but by myeloma protein.

Conclusion: - Radiotherapy is an effective local treatment for solitary bone plasmocytoma. Prospective studies are needed to better define predictive parameters of unfavourable outcome and indications of combined chemotherapy.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Biopsy
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / pathology
  • Bone Neoplasms / radiotherapy*
  • Bone Neoplasms / surgery
  • Cobalt Radioisotopes / therapeutic use
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Laminectomy
  • Male
  • Middle Aged
  • Multiple Myeloma / etiology
  • Plasmacytoma / drug therapy
  • Plasmacytoma / pathology
  • Plasmacytoma / radiotherapy*
  • Plasmacytoma / surgery
  • Radioisotope Teletherapy
  • Radiotherapy, High-Energy
  • Retrospective Studies
  • Spinal Neoplasms / drug therapy
  • Spinal Neoplasms / pathology
  • Spinal Neoplasms / radiotherapy
  • Spinal Neoplasms / surgery
  • Tibia / pathology
  • Time Factors
  • Treatment Outcome

Substances

  • Cobalt Radioisotopes